New York, NY (June 15, 2011) – Clinilabs, a full-service contract research organization that provides early phase and specialty clinical drug development services to industry, announced today that the company will exhibit at the Drug Information Association 47th Annual Meeting in Chicago, IL.
The annual meeting, which brings together leading companies in the drug development industry, will be held June 19-23 at McCormick Place. Clinilabs will be on site to showcase the company’s full range of early phase and specialty clinical drug development services that can be scaled as needed to meet the requirements of any clinical development program. The Clinilabs team will include President and CEO, Dr. Gary Zammit and Director of Business Development, Jeanine Estrada.
Attendees are invited to visit booth #1324, to learn more about Clinilabs’ offerings, as well as a chance to win an iPad.
About Clinilabs Inc.
Clinilabs is a full-service contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. One of the Company’s primary specialties is the development of therapeutic drugs and devices for sleep disorders. Clinilabs is recognized globally as a leading CRO in the field of sleep medicine, and has made important contributions to eleven successful new drug applications (NDAs) since 2001, For more information, please visit www.clinilabs.com.
For more information or to schedule an interview, please contact Hannah D’Aoust at 646.215.6411 or e-mail email@example.com.